Benefits and Harms of CT Screening for Lung Cancer
JAMA2012Vol. 307(22), pp. 2418–2418
Citations Over TimeTop 1% of 2012 papers
Peter B. Bach, Joshua N. Mirkin, Thomas K. Oliver, Christopher G. Azzoli, Donald A. Berry, Otis W. Brawley, Tim Byers, Graham A. Colditz, Michael K. Gould, James R. Jett, Anita L. Sabichi, Rebecca Smith‐Bindman, Douglas E. Wood, Amir Qaseem, Frank C. Detterbeck
Abstract
Low-dose computed tomography screening may benefit individuals at an increased risk for lung cancer, but uncertainty exists about the potential harms of screening and the generalizability of results.
Related Papers
- → Cost-Effectiveness of CT Screening in the National Lung Screening Trial(2014)544 cited
- → Screening for lung cancer(2014)17 cited
- → Stratification of NLST-ACRIN screening participants identifies the “sweet spot” of screening by identifying early stage lung cancers most amenable to curative surgery (N=10,054)(2017)2 cited
- → Implementation of a Lung Cancer-Screening Program(2013)1 cited
- → MS29.02 Defining Screening Frequency and Duration Using Risk Prediction Algorithms and CT Image Findings(2018)